臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yang c h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 241-265 / 1273 (共51頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-07-11T10:17:25Z	The development and evolution of lamellar macular hole in highly myopic eyes	Hsia Y.; Lee C.-Y.; Ho T.-C.; Yang C.-H.; CHUNG-MAY YANG
臺大學術典藏	2022-07-11T10:17:25Z	Full-thickness macular hole formation in proliferative diabetic retinopathy	Tsui M.-C.; Hsieh Y.-T.; Lai T.-T.; Lai C.-T.; Lin H.-C.; Ho T.-C.; Yang C.-H.; CHUNG-MAY YANG; Wang L.-C.
臺大學術典藏	2022-07-11T10:17:24Z	Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema�XA Two-Year Matched Comparative Study	Lai T.-T.; Chen T.-C.; Yang C.-H.; CHUNG-MAY YANG; Ho T.-C.; Hsieh Y.-T.
臺大學術典藏	2022-07-11T10:17:23Z	PREDICTED PROTEIN STRUCTURE VARIATIONS INDICATE THE CLINICAL PRESENTATION OF CYP4V2 -RELATED BIETTI CRYSTALLINE DYSTROPHY	Chan L.-W.; Sung Y.-C.; Wu D.-C.; Chen C.-Y.; Yang C.-H.; CHUNG-MAY YANG; Chen P.-L.; Chen T.-C.
臺大學術典藏	2022-07-11T10:17:23Z	HYPERREFLECTIVE FOCI AS IMPORTANT PROGNOSTIC INDICATORS OF PROGRESSION OF RETINITIS PIGMENTOSA	Huang C.-H.; Yang C.-H.; Lai Y.-J.; Hsiao C.K.; Hou Y.-C.; CHUNG-MAY YANG; Chen T.-C.
臺大學術典藏	2022-07-11T10:17:21Z	Quantitative analysis of branching neovascular networks in polypoidal choroidal vasculopathy by optical coherence tomography angiography after photodynamic therapy and anti-vascular endothelial growth factor combination therapy	Wang W.-Y.; Yang C.-H.; Chen T.-C.; Hsieh Y.-T.; Ho T.-C.; CHUNG-MAY YANG; Liu F.-Y.; Lai T.-T.
臺大學術典藏	2022-07-11T10:17:21Z	Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan	Cheng C.-K.; Chen S.-J.; Chen J.-T.; Chen L.-J.; Chen S.-N.; Chen W.-L.; Hsu S.-M.; Lai C.-H.; Sheu S.-J.; Wu P.-C.; Wu W.-C.; Wu W.-C.; CHUNG-MAY YANG; Yeung L.; Chen T.-C.; Yang C.-H.
臺大學術典藏	2022-06-27T07:07:55Z	High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy	Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; CHONG-JEN YU; Chang W.-C.; Kuo H.-P.; Yu C.-T.; Lin Z.-Z.; Kao W.-Y.
臺大學術典藏	2022-06-27T07:07:54Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; CHONG-JEN YU; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:54Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Wu S.-G.; Gow C.-H.; CHONG-JEN YU; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:53Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; CHONG-JEN YU; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-06-27T07:07:53Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; CHONG-JEN YU; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:51Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:07:49Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; CHONG-JEN YU; Cheng A.-L.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:47Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:45Z	Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer	Lee J.-H.; CHONG-JEN YU; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H.
臺大學術典藏	2022-06-27T07:07:45Z	Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors	Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:44Z	Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer	Wu J.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:44Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Lin C.-C.; Hsu H.-H.; Sun C.-T.; Shih J.-Y.; Lin Z.-Z.; CHONG-JEN YU; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; Yang C.-H.; Mok T.
臺大學術典藏	2022-06-27T07:07:42Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; CHONG-JEN YU; Chang S.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:36Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:35Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y.; CHONG-JEN YU; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:35Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Wu S.-G.; Yang C.-H.; CHONG-JEN YU; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:31Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:28Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.

顯示項目 241-265 / 1273 (共51頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856565
	造訪人次 : 53413849 線上人數 : 751 教育部委託研究計畫計畫執行:國立臺灣大學圖書館